Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.

Beijing is holding back its required green light for mergers that involve American companies as a technology war with Washington intensifies.

All those tech layoffs are starting to show up in employment statistics, but they still show little sign of spreading to other sectors.